• Make it like cafepharma, but for different industries: over the years we’ve had suggestions for creating a site similar to cafepharma, but for different industries. Now there is a place. Check out CompanyUnderground for company forums in other industries. Don’t see a company? Request it here. Let your friends and family outside the pharma/medical sales space know they now have a safe, anonymous place to talk.


Abilify Depot sales force

Quote

Anonymous

Guest
Is there any update as to when FDA approval will be granted? Also, what product will be the key competitor? My understanding is the call points will not be medical offices but rather institutions and hospitals with a direct buy and bill process. Can anyone provide any additional insight? Thanks!
 






Anonymous said:
Is there any update as to when FDA approval will be granted? Also, what product will be the key competitor? My understanding is the call points will not be medical offices but rather institutions and hospitals with a direct buy and bill process. Can anyone provide any additional insight? Thanks!
Click to expand...


Honey, I don't mean to be rude, but you would be better off doing some research on this board and elsewhere to find the answers to your questions. Everything you want to know has already been answered here, and you are just setting yourself up for some really offensive responses. Moreover, if you are only just asking these questions now, I think you might be coming too late to the party.
 






Darling, in the time you took to pen that reply you could have just simply taken the high road and answered the questions if you are privvy to the information being requested. What a kindhearted, selfless person you must be; I see where you clearly had no intention to be rude.
 






Anonymous said:
Is there any update as to when FDA approval will be granted? Also, what product will be the key competitor? My understanding is the call points will not be medical offices but rather institutions and hospitals with a direct buy and bill process. Can anyone provide any additional insight? Thanks!
Click to expand...

hey dumb dumb, its too late to be asking these questions. either you are in process or on board or you are late to the party. look for another job.
 






Anonymous said:
Darling, in the time you took to pen that reply you could have just simply taken the high road and answered the questions if you are privvy to the information being requested. What a kindhearted, selfless person you must be; I see where you clearly had no intention to be rude.
Click to expand...

Why. The person asking the questions should have already known the answers or they should not have been given a position calling on institutions or infusion clinics. There is something to be said for doing the leg work and finding out information on your own. People have to stop relying on the strength of others to hand them what they want to know because it isn't anyone else repsonsibility.
 






what is missing here is a realistic discussion of what government body (state or federal) is going to pay the price that this company will ask for this injectable? The oral formulation is over $500/month and this new formulation while it may be efficacious is not going to be cheap. Ask any Janssen rep what the problems are and it always comes back to cost! Should our taxes really be used to support such an expensive product that IS NOT MORE EFFICACIOUS than Haldol? Good luck with that whatever state you are in
 


















Sustena is the main competition. It is a piece of shit drug BUT there is a need for a long acting injection,BUT it is expensive. Who will pay ? Also read the clinical trials clinical trials.gov.it is going to be a pain in the ass to titrate for six weeks, and it is going to be a tough tough job.I was not chosen but I do wish those whose chosen luck. Unprofessional recruiters and a rookie manager that knew nothing about mental health turned me off.
 






Anonymous said:
what is missing here is a realistic discussion of what government body (state or federal) is going to pay the price that this company will ask for this injectable? The oral formulation is over $500/month and this new formulation while it may be efficacious is not going to be cheap. Ask any Janssen rep what the problems are and it always comes back to cost! Should our taxes really be used to support such an expensive product that IS NOT MORE EFFICACIOUS than Haldol? Good luck with that whatever state you are in
Click to expand...

Actually, Abilify is preferred by a big percentage of people with schizophrenia, so docs like it because there's better adherence. I've worked in behavioral health for years before I joined this team. The biggest challenge, besides compliance, for mental health centers and hospitals is the shortage of psychiatrists, and huge caseloads. Haldol is effective, but makes people feel like crap, so they have to be seen more often for symptoms. Ecause they don't take their meds. That means longer wait lists, and fewer patients (especially paying patients) get seen. Abilify has better adherence, and if it can be given monthly, it frees up slots for the doc. Federal grants and certain funding streams have an expectation for numbers of people served as well. Mental health is a relatively low percent of most Medicaid budgets anyway, and the priority for most of the states is to keep patients using public money out of the hospital.
 






Anonymous said:
Actually, Abilify is preferred by a big percentage of people with schizophrenia, so docs like it because there's better adherence. I've worked in behavioral health for years before I joined this team. The biggest challenge, besides compliance, for mental health centers and hospitals is the shortage of psychiatrists, and huge caseloads. Haldol is effective, but makes people feel like crap, so they have to be seen more often for symptoms. Ecause they don't take their meds. That means longer wait lists, and fewer patients (especially paying patients) get seen. Abilify has better adherence, and if it can be given monthly, it frees up slots for the doc. Federal grants and certain funding streams have an expectation for numbers of people served as well. Mental health is a relatively low percent of most Medicaid budgets anyway, and the priority for most of the states is to keep patients using public money out of the hospital.
Click to expand...

Abilify is used for bi polar and add on for depression mainly. Schizo is down the line. Lots of luck on this expensive injectable with your 7 "partners". LMAO
 






Anonymous said:
Abilify is used for bi polar and add on for depression mainly. Schizo is down the line. Lots of luck on this expensive injectable with your 7 "partners". LMAO
Click to expand...

18+ years 4,722 84.9%
2967 BIPOLAR AFFECTIVE NOS 1,102 23.3%
2957 SCHIZOAFFECTIVE TYPE 478 10.1%
2959 SCHIZOPHRENIA NOS 422 9.0%
2962 DEPR PSYCH, SINGL EPISOD 325 6.9%
3110 DEPRESSIVE DISORDER NEC 317 6.7%
2953 PARANOID SCHIZOPHRENIA 311 6.6%
2968 MANIC-DEPRESSIVE NEC/NOS 241 5.1%
2963 DEPR PSYCH, RECUR EPISOD 229 4.9%
2989 PSYCHOSIS NOS 207 4.4%
2969 AFFECT PSYCHOSES NEC/NOS 204 4.3%
All Others 886 18.8%
11/2009 to 03/2011
Table 5: Top Diagnoses Associated with the Use of Aripiprazole
According to U.S. Office-Based Physician Practices,

You can see that it is prescribed for psychosis related disorders 24.3%, Bipolar Disorder 23.3%, and Depression around 12%. My math isn't the greatest, so forgive me if I added incorrectly.
 






Anonymous said:
18+ years 4,722 84.9%
2967 BIPOLAR AFFECTIVE NOS 1,102 23.3%
2957 SCHIZOAFFECTIVE TYPE 478 10.1%
2959 SCHIZOPHRENIA NOS 422 9.0%
2962 DEPR PSYCH, SINGL EPISOD 325 6.9%
3110 DEPRESSIVE DISORDER NEC 317 6.7%
2953 PARANOID SCHIZOPHRENIA 311 6.6%
2968 MANIC-DEPRESSIVE NEC/NOS 241 5.1%
2963 DEPR PSYCH, RECUR EPISOD 229 4.9%
2989 PSYCHOSIS NOS 207 4.4%
2969 AFFECT PSYCHOSES NEC/NOS 204 4.3%
All Others 886 18.8%
11/2009 to 03/2011
Table 5: Top Diagnoses Associated with the Use of Aripiprazole
According to U.S. Office-Based Physician Practices,

You can see that it is prescribed for psychosis related disorders 24.3%, Bipolar Disorder 23.3%, and Depression around 12%. My math isn't the greatest, so forgive me if I added incorrectly.
Click to expand...

You have a long way to go to convince me that it is not being primarily used as an add on med. Keep in mind that the customer base that those figures were drawn from is going to be a fraction of what it was. In-patient units and CMHC's with a high SMI population will be the only places using injectables. Private practice and primary health will not use this med.
 






bms rep here - have any of the depot sales force for Otsuka been informed on when Otsuka will cut it's ties with bms and their promotion of Abilify orals - we were informed nothing will happen through 2013 but patten runs into 2015 (I think). Personally, I don't see why they would want bms around after 2013 - have any of you gotten direction / are you going to be promoting tabs as well ?? Thanks for any constructive feedback.
 












I guess my direct question would be this - will the new sales force sell tabs until the depot is approved and launched; and secondly, have you heard that bms will be completely done selling tabs at the conclusion of 2013? I do realize that the depot is strictly for schizo. We were lead to believe that bms would continue to be a part of the tabs promo through the entire patent life. Thanks.
 






Anonymous said:
I guess my direct question would be this - will the new sales force sell tabs until the depot is approved and launched; and secondly, have you heard that bms will be completely done selling tabs at the conclusion of 2013? I do realize that the depot is strictly for schizo. We were lead to believe that bms would continue to be a part of the tabs promo through the entire patent life. Thanks.
Click to expand...

Why did you not ask these questions during your interview process? It seems more than strange that you are now asking these questions. I guess you will probably try to reestablish or establish relationships with your physicians once you get out of training. There will be busy work, and you won't be sitting at home. BMS will, supposedly, be part of te tabs promo until the generic comes out. BMS is to be selling tabs thru 2014. We shall see. Why are you asking these questions HERE? It makes no sense to me. You should know this info.
 






Managment truely does not know the answer to this quesion- tab promotion till launch of depot as timing is everything on approval from FDA. The good thing about the situation is this.. and most companies right now hiring a new sales force(Ironwood, Chelsea..ect) are not in this position.. if the Depot gets pushed back(which from what we are hearing..not going to happen), then the sales force has the tabs to promote and be out in field until then.. not the offer depending on the approval letter that other companies are giving.. so relex and welcome!
 






Whole process a joke many people lied on their performance reviews to get a job, they hired many non-AP experienced people. It will be a tough go as money will be drying up. Good luck with the schzo focus many psych's feel Abilify weak drug for this indication.
 






Anonymous said:
what is missing here is a realistic discussion of what government body (state or federal) is going to pay the price that this company will ask for this injectable? The oral formulation is over $500/month and this new formulation while it may be efficacious is not going to be cheap. Ask any Janssen rep what the problems are and it always comes back to cost! Should our taxes really be used to support such an expensive product that IS NOT MORE EFFICACIOUS than Haldol? Good luck with that whatever state you are in
Click to expand...

Let's break this down. Abilify is mainly used for bipolar disorder and refractory depression (and psychs don't think it works for schizophrenia). The depot formulation will be--IF-- it gets approved-- for schizophrenia only. (People who have bipolar disorder or refractory depression do NOT get depot formulations of antipsychotics). Good luck. Instead of answering these questions, I'm running for the hills. C-ya.
 






Top Bottom
Back
Quote